LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets14Federal Circuit179Pharma & ANDA40PTAB150Supreme Court9USPTO Policy27Patent Litigation55Patent Prosecution20ITC / Section 33732Trademark43Unsorted35

Tagged quarterly · clear

USPTO Policy

Patexia Patent Insight 16: U.S. Patent Grants See Mild H1 2025 Decline, But Q2 Outpaces Q1

Patent issuance trends offer valuable insight into the pace of innovation, the workload at the U.S. Patent and Trademark Office (USPTO), and the overall health of the intellectual property ecosystem. Fluctuations in annual and quarterly grant numbers can…

August 14, 2025·USPTO Policy·2 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data